The α-Glucosidase Inhibitor 1-Deoxynojirimycin Blocks Human Immunodeficiency Virus Envelope Glycoprotein-Mediated Membrane Fusion at the CXCR4 Binding Step
Authors:
- 1 January 2002
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 61 (1) , 186-193
Abstract
1-Deoxynojirimycin (DNM) is a saccharide decoy that inhibits cellular α-glucosidase I-II activity. Treatment by DNM of human immunodeficiency virus (HIV)-infected lymphocyte cultures inhibits virus spread. The functional properties of the membrane-associated Env glycoprotein (Env) modified in the presence of DNM remain unclear because previous reports on this subject have essentially used recombinant soluble Envs whose properties differ notably from those of Env anchored on the surface of the virus. To model virus-associated Env synthesized in the presence of DNM, native Env was expressed at the surface of mammalian cells treated with DNM. As expected, its glycosylation pattern was altered in the presence of the inhibitor. Env was found able to bind CD4, whereas its ability to induce membrane fusion was abolished. The immunoreactivity of regions involved in interactions of Env with CXCR4 (V1, V2, C2, and V3) was modified and Env displayed altered interaction with this coreceptor. These results are consistent with the inhibition by DNM of virus entry at the Env/coreceptor interaction step. Finally, preliminary data indicate that suboptimal concentrations of DNM and natural or synthetic CXCR4 ligands used in combination potently inhibit the Env-mediated membrane fusion process. Altogether, our results suggest that DNM and its analogs deserve further investigation as anti-HIV agents in combination with experimental compounds targeting CXCR4 to inhibit each partner of this crucial step of HIV entry.Keywords
This publication has 40 references indexed in Scilit:
- The Catalytic Activity of Protein Disulfide Isomerase Is Involved in Human Immunodeficiency Virus Envelope–Mediated Membrane Fusion after CD4 Cell BindingThe Journal of Infectious Diseases, 2001
- An Anti-Human Immunodeficiency Virus Multiple Antigen Peptide Encompassing the Cleavage Region of the Env Precursor Interferes With Membrane Fusion at a Post-CD4 Binding StepVirology, 2000
- Relationships between the anti-HIV V3-derived peptide SPC3and lymphocyte membrane properties involved in virus entry: SPC3interferes with CXCR4FEMS Microbiology Letters, 2000
- A Dual-Tropic Primary HIV-1 Isolate That Uses Fusin and the β-Chemokine Receptors CKR-5, CKR-3, and CKR-2b as Fusion CofactorsCell, 1996
- Maturation and Assembly of Retroviral Glycoproteins1996
- Functions of HIV envelope glycansTrends in Biochemical Sciences, 1994
- Effect of a Glucosidase Inhibitor On The Bioactivity And Immunoreactivity of hUman Immunodeficiency Virus Type 1 Envelope GlycoproteinJournal of General Virology, 1991
- The V3 Loops of the HIV-1 and HTV-2 Surface Glycoproteins Contain Proteolytic Cleavage Sites: A Possible Function in Viral Fusion?AIDS Research and Human Retroviruses, 1991
- Attenuation of HIV-1 Infectivity by an Inhibitor of Oligosaccharide ProcessingAIDS Research and Human Retroviruses, 1990
- INHIBITORS OF THE BIOSYNTHESIS AND PROCESSING OF N-LINKED OLIGOSACCHARIDE CHAINSAnnual Review of Biochemistry, 1987